Endpoints News 2025년 11월 24일 J&J’s tau-targeting antibody fails Phase 2 Alzheimer's study #fails Phase #Alzheimer study
BioPharma Dive 2025년 11월 24일 Bayer’s experimental blood-thinner notches trial win in stroke prevention #Asundexian Phase #prevention Asundexian
BioWorld 2025년 11월 24일 Bayer’s asundexian hits phase III stroke goal in win for FXIa drugs #phase III #drugs Detailed
BioWorld 2025년 11월 24일 Novo’s semaglutide fails in phase III Alzheimer’s trials #phase III #III Alzheimer
BioWorld 2025년 11월 24일 Novo’s semaglutide fails in phase III Alzheimer’s trials #III Alzheimer #phase III
Endpoints News 2025년 11월 21일 Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial #Thursday afternoon #fails Phase
Roche Media 2025년 11월 18일 Roche reports positive Phase III data of giredestrant for breast cancer - Clinical Trials Arena #Phase III #Clinical Trials
Roche Media 2025년 11월 11일 Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena #Phase III #Clinical Trials
Roche Media 2025년 11월 10일 Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech #BTK inhibitor #Fierce Biotech
Roche Media 2025년 11월 3일 Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena #Phase III #III trial